Your browser doesn't support javascript.
loading
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party.
Necchi, A; Miceli, R; Bregni, M; Bokemeyer, C; Berger, L A; Oechsle, K; Schumacher, K; Kanfer, E; Bourhis, J H; Massard, C; Laszlo, D; Montoro, J; Flechon, A; Arpaci, F; Secondino, S; Wuchter, P; Dreger, P; Crysandt, M; Worel, N; Kruger, W; Ringhoffer, M; Unal, A; Nagler, A; Campos, A; Wahlin, A; Michieli, M; Sucak, G; Donnini, I; Schots, R; Ifrah, N; Badoglio, M; Martino, M; Raggi, D; Giannatempo, P; Rosti, G; Pedrazzoli, P; Lanza, F.
Afiliación
  • Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Miceli R; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Bregni M; Medical Oncology, Azienda Ospedaliera di Busto Arsizio, Busto Arsizio, Italy.
  • Bokemeyer C; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Berger LA; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Oechsle K; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Schumacher K; UKGM-Marburg Klinik for Hematology and Oncology, Marburg, Germany.
  • Kanfer E; Imperial College, Hammersmith Hospital, London, UK.
  • Bourhis JH; Gustave Roussy, Institut de cancérologie, Villejuif, France.
  • Massard C; Gustave Roussy, Institut de cancérologie, Villejuif, France.
  • Laszlo D; European Institute of Oncology, Milano, Italy.
  • Montoro J; European Institute of Oncology, Milano, Italy.
  • Flechon A; Centre Léon Bérard, Lyon, France.
  • Arpaci F; Gulhane Military Medical Academy, Ankara, Turkey.
  • Secondino S; Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Wuchter P; Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Dreger P; Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Crysandt M; University Hospital of Aachen, Aachen, Germany.
  • Worel N; University of Vienna, Vienna, Austria.
  • Kruger W; Universitätsmedizin, Greifswal, Germany.
  • Ringhoffer M; Klinikum Karlsruhe gGmbH, Karlsruhe, Germany.
  • Unal A; Kapadokya BMT Center, Kayseri, Turkey.
  • Nagler A; Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Campos A; Instituto Português de Oncologia do Porto, Porto, Portugal.
  • Wahlin A; Umea University Hospital, Umeå, Sweden.
  • Michieli M; Centro di Riferimento Oncologico, Aviano, Italy.
  • Sucak G; Gazi University of Medicine, Ankara, Turkey.
  • Donnini I; University Hospital of Careggi, Firenze, Italy.
  • Schots R; Universitair Ziekenhuis, Brussel, Belgium.
  • Ifrah N; Centre Hospitalier Universitaire (CHU), Angers, France.
  • Badoglio M; EBMT Study Office, EBMT, Paris, France.
  • Martino M; Azienda Ospedaliera BMM, Reggio Calabria, Italy.
  • Raggi D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Giannatempo P; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Rosti G; Ospedale Ca' Foncello, Treviso, Italy.
  • Pedrazzoli P; Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Lanza F; Istituti Ospitalieri di Cremona, Cremona, Italy.
Bone Marrow Transplant ; 51(3): 384-90, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26642334

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Terapia Recuperativa / Paclitaxel / Neoplasias de Células Germinales y Embrionarias / Quimioterapia de Inducción Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Terapia Recuperativa / Paclitaxel / Neoplasias de Células Germinales y Embrionarias / Quimioterapia de Inducción Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2016 Tipo del documento: Article